Skip to main content
Premium Trial:

Request an Annual Quote

UK s CSC/Imperial College Microarray Center to Use Rosetta Resolver

NEW YORK, March 7 (GenomeWeb News) - Rosetta Biosoftware said today that the MRC Clinical Sciences Center and Imperial College London have jointly licensed the Rosetta Resolver gene expression analysis platform for use in the CSC/Imperial College Microarray Center.

 

The research institutes, both based in London, licensed the system with funding from the UK's Medical Research Council and the British Heart Foundation.

 

Financial terms of the licensing agreement were not disclosed.

 

Last week, Rosetta announced that it had licensed the Resolver software to Serono.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.